NL-OMON26269尚未招募不适用
Validation hepatotoxicity-predictor-algorithm for patients with thiopurine drugs; A prospective observational study
n.a.0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •age > 18 years
- •patient agrees to take part in the study (signed informed consent)
排除标准
- •Known hypersensitivity to active substance or any of the excipients
- •Leukocytes <3 x 10^9 /l on baseline
研究者
相似试验
已完成
不适用
Validation hepatotoxicity-predictor-algorithm for patients with thiopurine drugs; A prospective observational studyCrohn's diseasechronic inflammatory bowel disease10017969ulcerative colitisNL-OMON42663Zuyderland Medisch Centrum250
已完成
不适用
iver safety analysis of Samsamani Vati/ Giloya ghana vati .CTRI/2022/06/043050JSS Ayurveda College30
招募中
不适用
Model development for the prediction of toxicity and prognosis in Korean elderly cancer patients receiving chemotherapy: a multicenter prospective studyKCT0001071Seoul National University Bundang Hospital200
已完成
不适用
PREDICTION OF RESPONSE AND TOXICITY IN PATIENTS WHO RECEIVE CHEMOTHERAPY FOR BREAST CANCER, CORRELATIVE STUDY OF GENOMICS, PROTEOMICS AND PHARMACOGENOMY-C509 Breast, unspecifiedBreast, unspecifiedC509PER-079-05HOSSIER ONCOLOGY GROUP,
已完成
不适用
PREDICTION OF RESPONSE AND TOXICITY IN PATIENTS WHO RECEIVE PACLITAXEL AND AVASTIN FOR BREAST CANCER. A CORRELATIVE, MULTICENTRIC, GENOMIC, PROTEOMIC AND PHARMACOGENIC STUDY-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-009-08HOSSIER ONCOLOGY GROUP,